Jenburkt Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	73.65	41.25	36.6	50.31	24.94
Short-Term Investments	-	157.79	698.44	458.25	415.55	495.14
Cash & Short-Term Investments	96.48	231.43	739.69	494.84	465.86	520.07
Cash Growth	-87.58%	-68.71%	49.48%	6.22%	-10.42%	-4.67%
Accounts Receivable	-	207.35	194.75	169.62	152.07	140.01
Other Receivables	-	11	50.02	42.28	21.31	43.02
Receivables	-	218.87	245.67	213.08	175.28	184.14
Inventory	-	88.8	85.66	83.38	98.98	76.17
Prepaid Expenses	-	11.59	6.77	4.59	5.53	4.36
Other Current Assets	-	14.61	19.49	15.02	13.39	15.13
Total Current Assets	-	565.32	1,097	810.91	759.04	799.87
Property, Plant & Equipment	-	547.06	112.14	112.19	113.05	104.47
Long-Term Investments	-	767.44	173.9	344.09	415.71	209.79
Goodwill	-	-	-	-	-	0.01
Other Intangible Assets	-	2.28	3.88	1.87	3.06	4.8
Long-Term Deferred Tax Assets	-	14.69	7.98	4.25	3.71	7.37
Other Long-Term Assets	-	64.89	255.51	144.23	133.59	84.71
Total Assets	-	1,962	1,651	1,418	1,429	1,212
Accounts Payable	-	81.55	62.57	60.97	71.1	45.92
Accrued Expenses	-	16.04	9.31	2.55	2.59	12.73
Short-Term Debt	-	19.79	-	24.39	58.15	37.11
Current Portion of Leases	-	4.23	-	4.89	4.51	4.17
Current Income Taxes Payable	-	2.86	16.41	3.37	0.77	2
Other Current Liabilities	-	63.72	75.49	61.46	75.67	78
Total Current Liabilities	-	188.19	163.79	157.62	212.8	179.92
Long-Term Leases	-	14.92	-	-	4.89	9.4
Long-Term Deferred Tax Liabilities	-	10.87	7.9	7.18	8.56	8.21
Other Long-Term Liabilities	-	30.1	29.91	29.43	29.43	29.65
Total Liabilities	-	244.09	201.59	194.22	255.67	227.17
Common Stock	-	44.13	44.13	44.13	45.89	45.89
Retained Earnings	-	1,657	1,375	1,165	1,119	942.57
Comprehensive Income & Other	-	16.76	30.62	15.25	9.2	-3.8
Shareholders' Equity	1,829	1,718	1,449	1,224	1,174	984.66
Total Liabilities & Equity	-	1,962	1,651	1,418	1,429	1,212
Total Debt	17.08	38.94	-	29.28	67.55	50.67
Net Cash (Debt)	79.41	192.5	739.69	465.57	398.31	469.4
Net Cash Growth	-89.49%	-73.98%	58.88%	16.89%	-15.15%	-4.92%
Net Cash Per Share	17.99	43.62	167.61	101.97	86.79	102.28
Filing Date Shares Outstanding	4.41	4.41	4.41	4.41	4.59	4.59
Total Common Shares Outstanding	4.41	4.41	4.41	4.41	4.59	4.59
Working Capital	-	377.12	933.49	653.29	546.24	619.95
Book Value Per Share	414.40	389.23	328.42	277.32	255.77	214.55
Tangible Book Value	1,825	1,715	1,446	1,222	1,171	979.85
Tangible Book Value Per Share	413.55	388.71	327.54	276.90	255.10	213.50
Buildings	-	117.96	107.24	103.86	101.39	96.73
Machinery	-	237.32	206.45	193.64	191.2	178.46
Construction In Progress	-	402.77	12.41	9.57	2.12	3.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.